Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
NASDAQ:GLSI

Greenwich LifeSciences 10/19/2023 Earnings Report

Greenwich LifeSciences logo
$12.08 +0.30 (+2.55%)
Closing price 04:00 PM Eastern
Extended Trading
$12.12 +0.04 (+0.29%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings HistoryForecast

Greenwich LifeSciences EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.22
Beat/Miss
Beat by +$0.03
One Year Ago EPS
N/A

Greenwich LifeSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Greenwich LifeSciences Announcement Details

Quarter
Date
10/19/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Greenwich LifeSciences Earnings Headlines

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
August 13 at 6:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/13/3132368/0/en/greenwich-lifesciences-announces-expansion-of-flamingo-01-into-romania.html
Greenwich LifeSciences, Inc. Provides Update on CEO Interviews and Corporate Events Related to GLSI-100 Development
August 11 at 6:19 AM  |  quiverquant.comQ
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
August 14 at 2:00 AM  |  Paradigm Press (Ad)
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
August 11 at 6:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3130703/0/en/greenwich-lifesciences-provides-update-on-ceo-interviews-corporate-events.html
Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis
May 9, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4784191-greenwich-life-sciences-what-the-recent-data-do-for-the-investment-thesis
Greenwich LifeSciences price target raised to $39 from $38 at H.C. Wainwright
April 22, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/greenwich-lifesciences-price-target-raised-to-39-from-38-at-h-c-wainwright-1034602502
See More Greenwich LifeSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Greenwich LifeSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenwich LifeSciences and other key companies, straight to your email.

About Greenwich LifeSciences

Greenwich LifeSciences (NASDAQ:GLSI), a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

View Greenwich LifeSciences Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles